PRMA Insights: The Roadmap to Pricing and Reimbursement Success
PRMA Insights: the Roadmap to Pricing and Reimbursement Success in Renal Cell Carcinoma
Use this 350+ page strategic resource to:
- Design a roadmap for your renal cell carcinoma product to achieve successful global market access
- Ensure your strategic plan reflects current and future market access realities
- Understand the pricing and reimbursement implications for immunotherapy and targeted therapies in the US, UK, France, Germany, Spain, Italy, and Japan
- Develop and refine pricing and reimbursement strategies
- Design your clinical development program to ensure relevant health economic and patient-reported outcome endpoints are captured
- Build forecast models that reflect market access realities
- Inform candidate selection and R&D portfolio prioritization
- Assess in-licensing opportunities and identify market access levers to negotiate favorable deal terms
- Develop an evidence-based value proposition in order to maximize deal value for your out-licensed product
To find out more about this publication and how it can help you optimize your product development download the brochure:
Download renal cell carcinoma brochure
Fill in the fields below and press submit. A member of our team
will respond
shortly.
prmainsights